S100A9 and Sepsis: In addition, S100A8 and S100A9 have been demonstrated to mediate endotoxin-induced cardiomyocyte dysfunction via the receptor for advanced glycation end products 30, which may change the condition of cardiomyocyte dysfunction as a result of sepsis, which the leading cause of death in the critically ill.